Third Rock closes debut fund on $378m(3)

Newly formed venture firm Third Rock Ventures will use its first fund for investments in early stage biotechnology companies.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this